Graham Melissa, Kizu Joanne, Devine Greg, McCallum Fiona, McPherson Brady, Auliff Alyson, Kaminiel Peter, Liu Wenjun
Australian Defence Force Malaria and Infectious Disease Institute, Enoggera, Brisbane, Queensland, Australia.
Queensland Institute of Medical Research-Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
IJID Reg. 2022 Mar 4;3:34-36. doi: 10.1016/j.ijregi.2022.02.009. eCollection 2022 Jun.
The first outbreak of chikungunya virus (CHIKV) was reported in West Sepik, Papua New Guinea (PNG) in June 2012, and spread rapidly throughout PNG. CHIKV imported from PNG to Queensland has been reported occasionally, but transmission of CHIKV in PNG remains unclear due to the lack of testing capability. This study investigated the degree of CHIKV exposure among PNG military personnel (PNGMP) in 2019, 7 years after its first emergence.
Sera of 204 PNGMP recruited in April 2019 was tested for the presence of anti-CHIKV immunoglobulin G (IgG) antibodies using a commercially available IgG detection kit, and anti-CHIKV neutralizing antibodies against a CHIKV Reunion strain using a neutralizing assay.
Anti-CHIKV seropositivity of the sera was 47% and 35%, respectively, using the enzyme-linked immunosorbent assay (ELISA) and neutralizing assay. Five percent (=11) of samples were found to be IgG negative or borderline, but neutralizing antibody positive.
The prevalence of anti-CHIKV neutralizing antibody of 35% suggests that CHIKV infection has become endemic among PNGMP. Current commercially available CHIKV ELISA detection kits may not be suitable for diagnostic purposes in multiple alphavirus endemic areas such as PNG, due to serological cross-reactivity among alphaviruses. Re-emergence of CHIKV in PNGMP is possible.
2012年6月,巴布亚新几内亚(PNG)西塞皮克首次报告基孔肯雅病毒(CHIKV)疫情,并迅速蔓延至整个PNG。偶尔有从PNG输入昆士兰的CHIKV报告,但由于缺乏检测能力,CHIKV在PNG的传播情况仍不清楚。本研究调查了CHIKV首次出现7年后,即2019年PNG军事人员(PNGMP)中CHIKV暴露的程度。
使用市售的IgG检测试剂盒,对2019年4月招募的204名PNGMP的血清进行抗CHIKV免疫球蛋白G(IgG)抗体检测,并使用中和试验检测针对CHIKV留尼汪毒株的抗CHIKV中和抗体。
使用酶联免疫吸附测定(ELISA)和中和试验,血清的抗CHIKV血清阳性率分别为47%和35%。发现5%(=11)的样本IgG呈阴性或临界值,但中和抗体呈阳性。
35%的抗CHIKV中和抗体流行率表明CHIKV感染在PNGMP中已成为地方病。由于甲病毒之间存在血清学交叉反应,目前市售的CHIKV ELISA检测试剂盒可能不适用于PNG等多个甲病毒流行地区的诊断。CHIKV在PNGMP中有可能再次出现。